Abstract
Pratibha P. Nair, Arathi Radhakrishnan, Mukesh Edavalathu, Joyal L. Joy
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2016
Immunological & metabolic responses to a therapeutic course of Basti in obesity
10.4103/0971-5916.162099 · 2015
Unresolved referenced work
2014
Vagus nerve stimulation in refractory epilepsy: effects on pro-and anti-inflammatory cytokines in peripheral blood
10.1159/000315530 · 2011
Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson's disease
10.1089/ars.2014.5859 · 2014
Parkinson disease
10.1111/ene.14108 · 2020
Dopaminergic cell death induced by MPP+, oxidant, and specific neurotoxicants share a common molecular mechanism
10.1046/j.1471-4159.2001.00096.x · 2001
Parkinson's disease and parkinsonism: neuropathology
10.1101/cshperspect.a009258 · 2012
Mitochondria, oxidative damage, and inflammation in Parkinson's disease
10.1111/j.1749-6632.2003.tb07470.x · 2003
Linking glycation and glycosylation with inflammation and mitochondrial dysfunction in parkinson's disease
10.3389/fnins.2018.00381 · 2018
Protein quality control by molecular chaperones in neurodegeneration
10.3389/fnins.2017.00185 · 2017
Inflammation and adaptive immunity in Parkinson's disease
10.1101/cshperspect.a009381 · 2012
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
10.1093/brain/awx056 · 2017
Regulation of striatal astrocytic receptor for advanced glycation end-products variants in an early stage of experimental Parkinson's disease
10.1111/jnc.13682 · 2016
TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of parkinson's disease
10.1007/978-1-4419-6612-4_56 · 2011
10.1074/jbc.m309304200
10.1074/jbc.m309304200 · 2004
Response by Sreejit and Nagareddy to a letter regarding the article, “neutrophil-Derived S100A8/A9 amplify granulopoiesis after myocardial infarction.”
10.1161/circulationaha.120.049408 · 2020
Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies
10.1186/s12974-018-1210-9 · 2018
Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics, and neuroimaging
10.1515/cclm-2014-0783 · 2015
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease
10.1016/j.bbrc.2006.05.011 · 2006
The predictive value of SS-16 in clinically diagnosed Parkinson's disease patients: Comparison with 99mTc-TRODAT-1 SPECT scans
10.1186/s40035-016-0062-4 · 2016
Oxidized DJ-1 as a possible biomarker of Parkinson's disease
10.3164/jcbn.13-108 · 2014
Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease
2011
Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease
10.1016/j.nbd.2008.11.011 · 2009
Unresolved referenced work
2013
10.1016/j.neulet.2009.11.065
10.1016/j.neulet.2009.11.065 · 2010
Serum uric acid in patients with parkinson's disease and vascular parkinsonism: a cross-sectional Study
10.1159/000342483 · 2013
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
2013
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
10.1093/brain/awq008 · 2010
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
10.1016/s1474-4422(11)70014-x · 2011
Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
10.1111/ene.12176 · 2014
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients
10.1371/journal.pone.0018513 · 2011
CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
10.1016/j.parkreldis.2014.01.011 · 2014
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
10.1002/ana.22311 · 2011
Elevated concentration of cerebrospinal fluid tissue transglutaminase in Parkinson's disease indicating apoptosis
10.1002/mds.20197 · 2004
The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in lewy body disease
10.3233/jad-2010-1289 · 2010
miRNA-124 in immune system and immune disorders
10.3389/fimmu.2016.00406 · 2016
Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease
10.1007/s10072-010-0335-0 · 2011
Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in parkinson's disease
10.3389/fnins.2021.689723 · 2021
10.1186/s13024-021-00427-6
10.1186/s13024-021-00427-6
Vagus nerve stimulation for treatment of inflammation: systematic review of animal models and clinical studies
10.15424/bioelectronmed.2016.00005 · doi-reference
[11C]PIB binding in Parkinson's disease dementia
10.1016/j.neuroimage.2007.09.072 · doi-reference
Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome
10.1371/journal.pone.0105328 · doi-reference
Vagus nerve stimulation and the cardiovascular System
10.1101/cshperspect.a034173 · doi-reference
Integrated network pharmacology, molecular docking and animal experiment to explore the efficacy and potential mechanism of baiyu decoction against ulcerative colitis by enema
10.2147/dddt.s432268 · doi-reference
Neurostimulation for neurogenic bowel dysfunction
10.1155/2013/563294 · doi-reference
Clinical efficacy of Panchamuladi Kaala Basti (enema) in the management of Amavata (Rheumatoid Arthritis)
10.4103/0974-8520.85737 · doi-reference
Effect of Kshara Basti and nirgundi Ghana Vati on amavata (Rheumatoid arthritis)
10.4103/0974-8520.100310 · doi-reference
Reduced risk of parkinson disease in patients with rheumatoid arthritis: a nationwide population-based Study
10.1016/j.mayocp.2016.06.023 · doi-reference
Self-administration of right vagus nerve stimulation activates midbrain dopaminergic nuclei
10.3389/fnins.2021.782786 · doi-reference
Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease
10.1016/s0022-510x(00)00329-4 · doi-reference
Role of Gut Microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis
10.3390/microorganisms8040527 · doi-reference
Vagal sensory neurons and gut-brain signalling
10.1016/j.conb.2020.03.006 · doi-reference
Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes
10.1007/s00592-023-02088-x · doi-reference
Rectal distention-induced colonic net water secretion in rats involves tachykinins, capsaicin sensory, and vagus nerves
10.1016/s0016-5085(97)70041-6 · doi-reference
Sensory neurons that detect stretch and nutrients in the digestive System
10.1016/j.cell.2016.05.011 · doi-reference
Internal senses of the vagus nerve
10.1016/j.neuron.2021.12.020 · doi-reference
Gut sensory neurons as regulators of neuro-immune-microbial interactions: from molecular mechanisms to precision therapy for IBD/IBS
10.1186/s12974-025-03500-9 · doi-reference
Basti: does the equipment and method of administration matter?
10.4103/0975-9476.109543 · doi-reference
Intestinal lipid–derived signals that sense dietary fat
10.1172/jci76302 · doi-reference
Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson's Disease
10.3390/cells9020376 · doi-reference
Efficacy of Virechana and Basti Karma with Shamana therapy in the management of essential hypertension: a comparative study
10.4103/0974-8520.115455 · doi-reference
Ayurvedic management of chronic constipation in Hirschsprung disease - a case study
10.1016/j.jaim.2017.11.004 · doi-reference
Effect of Anuvasana Basti with Ksheerabala Taila in Sandhigata Vata (Osteoarthritis)
10.4103/0974-8520.146225 · doi-reference
Clinical study on the efficacy of Rajayapana Basti and Baladi Yoga in motor disabilities of cerebral palsy in children
10.4103/0974-8520.153748 · doi-reference
A case study on the Ayurvedic management of cerebral palsy
10.4103/0257-7941.157163 · doi-reference
Efficacy of Āyurvedic treatment using Pañcakarma combined with balance exercises for disability and balance in progressive supranuclear palsy
10.4103/0257-7941.113793 · doi-reference
Management of Parkinson's disease in Ayurveda: medicinal plants and adjuvant measures
10.1016/j.jep.2016.08.020 · doi-reference
Can the vagus nerve serve as a biomarker for Vata dosha activity?
10.1016/j.jaim.2019.04.003 · doi-reference
Parkinson's disease: biomarkers, treatment, and risk factors
10.3389/fnins.2018.00612 · doi-reference
Meta-analysis of the relationship between Parkinson's disease and melanoma
10.1212/wnl.0b013e31821e554e · doi-reference
Serum Iron levels and the risk of parkinson disease: a mendelian randomization study
10.1371/annotation/c4d81646-0c0e-4a3e-9425-b220bae2d8b6 · doi-reference
Anemia of inflammation
10.1016/j.hoc.2014.04.005 · doi-reference
Oxidative stress, eryptosis, and anemia: a pivotal mechanistic nexus in systemic diseases
10.1111/febs.14606 · doi-reference
Inflammasomes: mechanism of action, role in disease, and therapeutics
10.1038/nm.3893 · doi-reference
Depression and cognitive impairment in parkinson's disease: a role for inflammation and immunomodulation?
10.1159/000356531 · doi-reference
Major depressive disorder in Parkinson's disease: a register-based study
10.1034/j.1600-0447.2002.02229.x · doi-reference
Differential effects of vagus nerve stimulation strategies on glycemia and pancreatic secretions
10.14814/phy2.14479 · doi-reference
Parkinson's disease, insulin resistance and novel agents of neuroprotection
10.1093/brain/aws009 · doi-reference
Blood dendritic cell frequency declines in idiopathic parkinson's disease and is associated with motor symptom severity
10.1371/journal.pone.0065352 · doi-reference